UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy Journal article
Wang S., Xu Y., Chan H.F., Kim H.-W., Wang Y., Leong K.W., Chen M.. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy[J]. Journal of Controlled Release, 2016, 240, 454.
Authors:  Wang S.;  Xu Y.;  Chan H.F.;  Kim H.-W.;  Wang Y.; et al.
Favorite | TC[WOS]:42 TC[Scopus]:45  IF:10.5/10.6 | Submit date:2018/10/31
Apoptosis  Cancer  Drug Resistance  Nanoparticles  Survivin  
Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression Journal article
Wang S., Wang L., Chen M., Wang Y.. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression[J]. Chemico-Biological Interactions, 2015, 235, 76.
Authors:  Wang S.;  Wang L.;  Chen M.;  Wang Y.
Favorite | TC[WOS]:63 TC[Scopus]:68 | Submit date:2018/10/30
Doxorubicin  Gambogic Acid  Multidrug Resistance  P-glycoprotein  Survivin  
Expression of anaplastic lymphoma kinase and survivin proteins in anaplastic large cell lymphoma and its significance Journal article
Li J.-F., Li G.-D., Liu W.-P., Wang Y., Cheng J.-R., Chen Y., Yang H., Tang H.-L., Bai Y.-Q., Lin D.-G., Du L.-H., Peng F.-X., Yang Y.-H., Zhao C.. Expression of anaplastic lymphoma kinase and survivin proteins in anaplastic large cell lymphoma and its significance[J]. Chinese Journal of Pathology, 2006, 35(4), 213-217.
Authors:  Li J.-F.;  Li G.-D.;  Liu W.-P.;  Wang Y.;  Cheng J.-R.; et al.
Favorite | TC[Scopus]:4 | Submit date:2019/01/16
Anaplastic Lymphoma Kinase  Immunohistochemistry  Non-hodgkin Lymphoma  Survivin